Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
Tilray shares jumped after announcing it successfully imported medical cannabis into the U.S. in support of a new clinical trial on its use for treating breast cancer drug side effects
Ikänik Farms is looking to go public in the next several months, and CEO Brian Baca tells Mugglehead its Pideka acquisition will "crush everybody coming out of Canada" with its low-cost cultivation and export potential.
Mugglehead talks to Everett Knight, executive vice president of strategy and investments at Valens, how the extraction company's focus on quality is helping it land big contracts ahead of Cannabis 2.0.
The two companies said they have been pouring in resources the last five months to develop water soluble pot drinks they expect will make a big splash in the $2.7 billion derivatives market.
Researchers at the Mayo Clinic examine lung tissue samples from 17 patients associated with the vaping health crisis that has sickened 1,080 Americans since April.
With more than 800 cases of vape-related lung disorders and 17 confirmed deaths, 800 cannabis companies signed a letter to Congress to regulate the industry to keep consumers safe.
The study, published in the Journal of Neuroscience, shows for the first time how CBD cancels out the negative side-effects of THC in rats such as paranoia, anxiety and addictive behaviours.
U.S. Epidiolex sales have surged on strong patient uptake and now the CBD-based epilepsy drug could be sold in 31 European countries after EU authorities gave GW the green light.
Amid a breakout of vape-related lung illnesses in the U.S., the industry is calling for products to be regulated, while in Canada, pot firms say their legal vapes are rigorously tested and safe.
Mugglehead speaks with Dr. Arup Sen, chief science officer at Sproutly, about its industry-leading technology used to develop high quality infused beverages with precise THC dosing.
Mugglehead talks to University of British Columbia's M-J Milloy who is studying how cannabis might help with opioid addiction while big pharma is being sued for millions.
The recent University of Michigan survey comes on the heals of a separate U.S. report that shows high school students are using less pot, but either way, the industry knows it needs to show social responsibility.
Two deaths and hundreds of cases of a mysterious lung illness all linked to vaping e-cigarettes or illegal cannabis oil in the U.S. has sparked investigations in Canada and south of the border.
The U.S. Centers for Disease Control is investigating 94 reports of people in hospitals with vape-related lung illnesses across 14 states with a number of cases related to the use of illegal cannabis vape cartridges.
A Tel Aviv-based team at Weedley is launching several clinical studies to test if CBD is an effective and safe way to treat pain in dogs and horses.
Aurora and the UFC plan to conduct clinical trials to study how CBD can help the elite athletes and the results will be used develop a new line of hemp-derived topical products.
Health Canada has only approved only 65 of approximately 600 cannabis research applications since legalization took place Oct. 17, according to a recent CTV News report.
It took eight years and $83 million dollars for Tel Aviv-based Syqe Medical to develop the new product that will allow medical marijuana patients to take accurate doses.
Toronto-based CannaHorse announced Wednesday it launched the world's first-ever legal cannabis brand dedicated to horse health.
Next fall, the University of Maryland School of Pharmacy will offer a two-year master's program designed for health care practitioners, scientists, regulators, and industry professionals.
The Trudeau government said the money will be split between 13 different organizations across Canada to raise awareness on the harms associated with cannabis use.
More women are using marijuana during pregnancy in the U.S. and that might be causing health issues for their babies, two new studies suggest.
Parents and educators in the first U.S. states to legalize recreational cannabis are growing concerned about young people having increased access to highly potent pot.
In a study at the Hebrew University of Jerusalem, researchers found rodents treated with a cannabinoid derived from cannabis had significantly better recoveries.
Advancing study into the substance is “something that wouldn't be possible in the prohibition era,” said Rebecca Haines-Saah of the University of Calgary.
